Femasys (FEMY) vs Pulsenmore (PLSM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Femasys is the larger company by market cap ($17.1 million vs $12.5 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FEMY | PLSM |
|---|---|---|
| Share price | $2.05 | $1.92 |
| Market cap | $17.13M | $12.49M |
| 1-day change | +2.25% | +0.73% |
| YTD return | -82.25% | — |
| 1-year return | -82.87% | — |
| 5-year return | -98.54% | — |
| EPS (TTM) | $-3.28 | $-1.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $22.20 | $12.97 |
| 52-week low | $1.94 | $1.83 |
| Distance from 52-week high | -90.79% | -85.20% |
| Analyst consensus | none | — |
| Avg. price target upside | +600.73% | — |
| Average volume | 721.18K | 470.95K |
| Shares outstanding | 8.38M | 6.50M |
| Employees | 51 | 71 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Femasys
FEMY stock →Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation.
Healthcare · Medical Instruments & Supplies · 51 employees
About Pulsenmore
PLSM stock →Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products in the United States, the United Kingdom, Northern Ireland, and Europe.
Healthcare · Medical Devices · 71 employees
FEMY vs PLSM FAQ
Which is bigger, Femasys or Pulsenmore?
Femasys (FEMY) is larger, with a market capitalization of $17.13M compared with $12.49M for Pulsenmore (PLSM).
Are Femasys and Pulsenmore in the same industry?
Both are in the Healthcare sector, but in different industries: Medical Instruments & Supplies for Femasys and Medical Devices for Pulsenmore.